Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

180 Life Sciences Corp. Warrant (ATNFW)

Pharmaceutical Preparations

https://www.180lifesciences.com

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

3000 EL CAMINO REAL, BLDG 4, STE 200
PALO ALTO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/27/2017

Market Cap

1,294,380

Shares Outstanding

6,740,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ARTLW --.--%

ATNF --.--%

RVPHW --.--%

ADILW --.--%

ENTXW --.--%

Beta

0.4360

Last Div

0.0000

Range

0.0073-0.0083

Chg

-0.0028

Avg Vol

N/A

Mkt Cap

1294380

Exch

NASDAQ

Country

US

Phone

650 507 0669

DCF Diff

0.2003

DCF

1.7298

Div Yield

0.0000

P/S

10.8623

EV Multiple

-0.1246

P/FV

-4.0901

Div Yield %

0.0000

P/E

-0.1362

PEG

-0.0016

Payout

0.0000

Current Ratio

0.5845

Quick Ratio

0.5845

Cash Ratio

0.2854

DSO

21.8938

DIO

0.0000

Op Cycle

21.8938

DPO

10356.2073

CCC

-10334.3135

Gross Margin

0.3802

Op Margin

-53.7848

Pretax Margin

-89.7443

Net Margin

-75.5937

Eff Tax Rate

0.1577

ROA

-3.2087

ROE

30.4352

ROCE

85.3049

NI/EBT

0.8423

EBT/EBIT

1.6686

EBIT/Rev

-53.7848

Debt Ratio

0.1131

D/E

-1.0581

LT Debt/Cap

-0.0328

Total Debt/Cap

18.2025

Int Coverage

-333.7652

CF/Debt

-9.5905

Equity Multi

-9.3578

Rec Turnover

16.6714

Pay Turnover

0.0352

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0424

OCF/Share

-4.6149

FCF/Share

-4.6149

Cash/Share

1.2471

OCF/Sales

-25.5480

FCF/OCF

1.0000

CF Coverage

-9.5905

ST Coverage

-9.8876

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-4.0901

P/B

-4.0901

P/S

10.8623

P/E

-0.1362

P/FCF

-0.4252

P/OCF

-0.4030

P/CF

-0.4030

PEG

-0.0016

P/S

10.8623

EV Multiple

-0.1246

P/FV

-4.0901

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation